Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Head and Neck Neoplasms 2 Zollinger-Ellison Syndrome 1 Thrombosis 1 Thromboembolism 1 Stomach Ulcer 1 Squamous Cell Carcinoma of Head and Neck 1 Salivary Gland Neoplasms 1 Polycythemia Vera 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, Follicular 1 Ischemic Stroke 1 Esophagitis, Peptic 1 Breast Neoplasms 1 Adenocarcinoma 1

Interventions

Oxaliplatin 46 Gemcitabine 45 Fluorouracil 40 Capecitabine 31 pembrolizumab 30 Leucovorin 29 Docetaxel 27 Cisplatin 25 Paclitaxel 23 Irinotecan 18 Carboplatin 18 Bevacizumab 18 130-nm albumin-bound paclitaxel 17 Radiotherapy 16 Pemetrexed 15 Albumin-Bound Paclitaxel 15 Nivolumab 13 Ramucirumab 11 Cyclophosphamide 11 Drug Therapy 9 Trastuzumab 8 Erlotinib Hydrochloride 8 zolbetuximab 7 Taxes 7 Radiosurgery 7 trastuzumab deruxtecan 6 cemiplimab 6 Blood Specimen Collection 6 regorafenib 5 durvalumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Adenocarcinoma × Clopidogrel × Clear all

NCT02404363 2019-07-25

PANCREADOGREL

Assistance Publique - Hôpitaux de Paris

Phase 3 Terminated

Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡